Back to Results
First PageMeta Content
Health / Corrective lenses / Ophthalmology / Clinical endpoint / Clinical research / Bandage / Cataract / Intraocular lens / Medicine / Eye surgery / Blindness


FDA Executive Summary Prepared for the September 19, 2013 meeting of the Ophthalmic Devices Advisory Panel of the Medical Devices Advisory Committee
Add to Reading List

Open Document

File Size: 2,74 MB

Share Result on Facebook

Company

ITT / /

Country

United States / /

Currency

pence / /

Event

FDA Phase / /

IndustryTerm

subject device / manufacturing sections / external energy requirements / breakdown products / diluent solution / borate salt solution / study protocol / /

MedicalCondition

clear corneal cataract / infection / Peripheral corneal edema / corneal astigmatism / cataract / /

MedicalTreatment

Incision / surgery / Surgical Treatment / cataract surgery / Radiation / incisions / /

Organization

Ophthalmic Devices Advisory Panel of the Medical Devices Advisory Committee P130004 Ocular Therapeutix ReSure / FDA / /

Position

Executive / /

Product

polyethylene glycol / P130004 / G110114 / United States / /

ProvinceOrState

Virginia / /

Technology

study protocol / radiation / /

SocialTag